Azzad Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,815
| Closed | -$909K | – | 322 |
|
|
2020
Q4 | $909K | Buy |
5,815
+29
| +0.5% | +$3.73K | 0.16% | 200 |
|
|
2020
Q3 | $662K | Buy |
5,786
+912
| +19% | +$98.4K | 0.14% | 214 |
|
|
2020
Q2 | $547K | Buy |
+4,874
| New | +$517K | 0.13% | 228 |
|
|
2020
Q1 | – | Sell |
-7,123
| Closed | -$790K | – | 358 |
|
|
2019
Q4 | $790K | Sell |
7,123
-36
| -0.5% | -$3.85K | 0.09% | 267 |
|
|
2019
Q3 | $771K | Buy |
7,159
+4,877
| +214% | +$550K | 0.1% | 265 |
|
|
2019
Q2 | $299K | Sell |
2,282
-30
| -1% | -$3.87K | 0.08% | 270 |
|
|
2019
Q1 | $313K | Sell |
2,312
-3
| -0.1% | -$373 | 0.09% | 260 |
|
|
2018
Q4 | $225K | Sell |
2,315
-194
| -8% | -$22.9K | 0.08% | 288 |
|
|
2018
Q3 | $349K | Sell |
2,509
-64
| -2% | -$8.03K | 0.09% | 284 |
|
|
2018
Q2 | $319K | Buy |
2,573
+47
| +2% | +$5.49K | 0.09% | 280 |
|
|
2018
Q1 | $282K | Buy |
2,526
+53
| +2% | +$6.33K | 0.09% | 278 |
|
|
2017
Q4 | $296K | Buy |
2,473
+95
| +4% | +$11.6K | 0.09% | 260 |
|
|
2017
Q3 | $334K | Buy |
2,378
+85
| +4% | +$11.5K | 0.11% | 251 |
|
|
2017
Q2 | $279K | Sell |
2,293
-5,921
| -72% | -$689K | 0.1% | 269 |
|
|
2017
Q1 | $996K | Buy |
8,214
+161
| +2% | +$20.8K | 0.38% | 102 |
|
|
2016
Q4 | $985K | Buy |
8,053
+47
| +0.6% | +$5.75K | 0.41% | 85 |
|
|
2016
Q3 | $981K | Sell |
8,006
-38
| -0.5% | -$4.89K | 0.4% | 94 |
|
|
2016
Q2 | $939K | Buy |
8,044
+1,367
| +20% | +$194K | 0.4% | 90 |
|
|
2016
Q1 | $930K | Buy |
6,677
+106
| +2% | +$15.6K | 0.41% | 94 |
|
|
2015
Q4 | $1.25M | Buy |
6,571
+40
| +0.6% | +$6.99K | 0.6% | 43 |
|
|
2015
Q3 | $1.02M | Buy |
6,531
+86
| +1% | +$15.7K | 0.54% | 62 |
|
|
2015
Q2 | $1.17M | Sell |
6,445
-18
| -0.3% | -$3.11K | 0.59% | 49 |
|
|
2015
Q1 | $1.12M | Buy |
6,463
+38
| +0.6% | +$6.88K | 0.54% | 50 |
|
|
2014
Q4 | $1.19M | Buy |
6,425
+91
| +1% | +$16.9K | 0.63% | 33 |
|
|
2014
Q3 | $1.05M | Buy |
6,334
+73
| +1% | +$12K | 0.61% | 33 |
|
|
2014
Q2 | $978K | Buy |
6,261
+8
| +0.1% | +$1.26K | 0.59% | 38 |
|
|
2014
Q1 | $938K | Buy |
6,253
+101
| +2% | +$16.1K | 0.62% | 29 |
|
|
2013
Q4 | $817K | Buy |
6,152
+119
| +2% | +$14.3K | 0.59% | 42 |
|
|
2013
Q3 | $701K | Hold |
6,033
| – | – | 0.58% | 49 |
|
|
2013
Q2 | $587K | Buy |
+6,033
| New | +$581K | 0.5% | 61 |
|
Other funds holding ALXN
FCM
HI
PCM
DKCM
BBA
